Singapore vs Sweden: Previously treated cases tested for RR-/MDR-TB
Singapore
49.0%
in 2024
Sweden
50.0%
in 2024
Singapore rank
151st
Sweden rank
150th
Previously treated cases tested for RR-/MDR-TB over time
- Singapore
- Sweden
How they compare
Sweden currently reports 50.0% against 49.0% in Singapore, a difference of 1.0%.
The two have swapped places 11 times across 20 shared years of data; in 2005 it was Singapore ahead.
Singapore ranks 151st and Sweden ranks 150th of 180 countries.
Across the 3 decades both report, Singapore averaged higher in 2 and Sweden in 1.
Head to head by decade
| Decade | Singapore | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 66.6% | 74.6% | 8.0% | Sweden |
| 2010s | 68.5% | 63.0% | 5.5% | Singapore |
| 2020s | 72.2% | 71.0% | 1.2% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Singapore or Sweden?
- Sweden, at 50.0% against 49.0% in Singapore as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Singapore and Sweden?
- 1.0%, with Sweden ahead.
- How many years of comparable data are there for Singapore and Sweden?
- 20 years are reported by both, from 2005 to 2024.
- How do Singapore and Sweden rank globally for previously treated cases tested for rr-/mdr-tb?
- Singapore ranks 151st and Sweden ranks 150th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.